BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9495357)

  • 1. Increased expression of estrogen-receptor exon-5-deletion variant in relapse tissues of human breast cancer.
    Gallacchi P; Schoumacher F; Eppenberger-Castori S; Von Landenberg EM; Kueng W; Eppenberger U; Mueller H
    Int J Cancer; 1998 Feb; 79(1):44-8. PubMed ID: 9495357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of alternatively spliced estrogen receptor alpha mRNAs is increased in breast cancer tissues.
    Poola I; Speirs V
    J Steroid Biochem Mol Biol; 2001 Nov; 78(5):459-69. PubMed ID: 11738556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer.
    Daffada AA; Johnston SR; Smith IE; Detre S; King N; Dowsett M
    Cancer Res; 1995 Jan; 55(2):288-93. PubMed ID: 7812959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple splicing variants of the estrogen receptor are present in individual human breast tumors.
    Zhang QX; Hilsenbeck SG; Fuqua SA; Borg A
    J Steroid Biochem Mol Biol; 1996 Nov; 59(3-4):251-60. PubMed ID: 9010317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of estrogen receptor alpha exon 5 and 7 deletion variant in human breast cancers.
    Omoto Y; Iwase H; Iwata H; Hara Y; Toyama T; Ando Y; Kobayashi S
    Breast Cancer; 2000 Jan; 7(1):27-31. PubMed ID: 11029767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative splicing of the estrogen receptor primary transcript normally occurs in estrogen receptor positive tissues and cell lines.
    Pfeffer U; Fecarotta E; Arena G; Forlani A; Vidali G
    J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):99-105. PubMed ID: 8603053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular aspects of estrogen receptor variants in breast cancer.
    Fuqua SA; Wolf DM
    Breast Cancer Res Treat; 1995 Sep; 35(3):233-41. PubMed ID: 7579493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel estrogen receptor variant mRNA lacking exons 4 to 6 in breast carcinoma.
    Chan CM; Dowsett M
    J Steroid Biochem Mol Biol; 1997 Aug; 62(5-6):419-30. PubMed ID: 9449245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor beta splice variant mRNAs are differentially altered during breast carcinogenesis.
    Poola I; Abraham J; Liu A
    J Steroid Biochem Mol Biol; 2002 Oct; 82(2-3):169-79. PubMed ID: 12477483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line.
    Castles CG; Fuqua SA; Klotz DM; Hill SM
    Cancer Res; 1993 Dec; 53(24):5934-9. PubMed ID: 8261406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor variants in normal human mammary tissue.
    Leygue ER; Watson PH; Murphy LC
    J Natl Cancer Inst; 1996 Mar; 88(5):284-90. PubMed ID: 8614007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of estrogen receptor variant messenger RNAs in human breast cancer.
    Leygue E; Huang A; Murphy LC; Watson PH
    Cancer Res; 1996 Oct; 56(19):4324-7. PubMed ID: 8813116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type estrogen receptor in human breast cancer.
    Zhang QX; Borg A; Fuqua SA
    Cancer Res; 1993 Dec; 53(24):5882-4. PubMed ID: 8261397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variant human breast tumor estrogen receptor with constitutive transcriptional activity.
    Fuqua SA; Fitzgerald SD; Chamness GC; Tandon AK; McDonnell DP; Nawaz Z; O'Malley BW; McGuire WL
    Cancer Res; 1991 Jan; 51(1):105-9. PubMed ID: 1988075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of exon 5 deleted estrogen receptor variant messenger RNA in human uterine myometrium and leiomyoma.
    Mito K; Tamura T; Hosokawa K; Kondo T; Yamamoto T; Honjo H
    J Steroid Biochem Mol Biol; 1998 Oct; 67(1):9-16. PubMed ID: 9780024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of exon 5-deleted oestrogen receptor in human breast cancer: functional analysis and clinical significance.
    Desai AJ; Luqmani YA; Walters JE; Coope RC; Dagg B; Gomm JJ; Pace PE; Rees CN; Thirunavukkarasu V; Shousha S; Groome NP; Coombes R; Ali S
    Br J Cancer; 1997; 75(8):1173-84. PubMed ID: 9099967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of clone 4 estrogen receptor variant messenger RNA expression to some known prognostic variables in human breast cancer.
    Murphy LC; Hilsenbeck SG; Dotzlaw H; Fuqua SA
    Clin Cancer Res; 1995 Feb; 1(2):155-9. PubMed ID: 9815968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of estrogen receptor beta messenger RNA variant in breast cancer.
    Vladusic EA; Hornby AE; Guerra-Vladusic FK; Lupu R
    Cancer Res; 1998 Jan; 58(2):210-4. PubMed ID: 9443393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of estrogen receptor-alpha variant messenger RNAs between adjacent normal breast and breast tumor tissues.
    Leygue E; Dotzlaw H; Watson PH; Murphy LC
    Breast Cancer Res; 2000; 2(1):64-72. PubMed ID: 11400682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wild type and alternatively spliced estrogen receptor messenger RNA in human meningioma tissue and MCF7 breast cancer cells.
    Koehorst SG; Jacobs HM; Thijssen JH; Blankenstein MA
    J Steroid Biochem Mol Biol; 1993 Apr; 45(4):227-33. PubMed ID: 8499331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.